Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase 1b, Multicenter, Randomized, Open-Label Study to Investigate the Impact of the Administration of Intravenous VH3810109 With or Without Oral Fostemsavir in Combination With Integrase Inhibitor-Based Antiretroviral Therapy on the Viral Reservoir in Adults Living With HIV-1

NCT07053384 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT07053384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07053384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase 1b, Multicenter, Randomized, Open-Label Study to Investigate the Impact of the Administration of Intravenous VH3810109 With or Without Oral Fostemsavir in Combination With Integrase Inhibitor-Based Antiretroviral Therapy on the Viral Reservoir in Adults Living With HIV-1
Lead sponsor
ViiV Healthcare
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 10, 2025
Completion date
September 6, 2028
Enrollment
107 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections